España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Ocular Therapeutix
OCUL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.77
-0.12
-1.21%
At close: -
$9.72
-0.05
-0.51%
After Hours: 6:52 PM EDT
Get Report
Comment
Ocular Therapeutix (OCUL) Forecast
News
Earnings
Ocular Therapeutix (OCUL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Ocular Therapeutix (NASDAQ:OCUL) Stock
Ocular Therapeutix Stock (NASDAQ: OCUL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 02, 2024
Ocular Therapeutix Announced That More Than 3...
Benzinga Newsdesk
Friday, November 15, 2024
HC Wainwright & Co. Maintains Buy on Ocular T...
Benzinga Newsdesk
Thursday, November 14, 2024
Ocular Therapeutix's Cash Balance Of $427.2M ...
Benzinga Newsdesk
Ocular Therapeutix Q3 2024 GAAP EPS $(0.22) B...
Benzinga Newsdesk
Earnings Scheduled For November 14, 2024
Benzinga Insights
Wednesday, November 13, 2024
A Peek at Ocular Therapeutix's Future Earnings
Benzinga Insights
Wednesday, October 16, 2024
Ocular Therapeutix shares are trading higher ...
Benzinga Newsdesk
Scotiabank Initiates Coverage On Ocular Thera...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk
Tuesday, October 15, 2024
Ocular Therapeutix Fast-Tracks SOL-1 Registra...
Benzinga Newsdesk
Thursday, August 08, 2024
Baird Maintains Outperform on Ocular Therapeu...
Benzinga Newsdesk
Wednesday, August 07, 2024
Ocular Therapeutix' Cash Balance Of $459.7M A...
Benzinga Newsdesk
Ocular Therapeutix Q2 2024 GAAP EPS $(0.26) M...
Benzinga Newsdesk
Ocular Therapeutix Has Received FDA Written R...
Benzinga Newsdesk
Thursday, August 01, 2024
Beyond The Numbers: 8 Analysts Discuss Ocular Therapeutix Stock
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk
Tuesday, July 30, 2024
Ocular Therapeutix Enrolls First Patients In ...
Benzinga Newsdesk
Wednesday, July 10, 2024
Ocular Therapeutix To Present Late-Breaking A...
Benzinga Newsdesk
Friday, June 21, 2024
Piper Sandler Maintains Overweight on Ocular ...
Benzinga Newsdesk
Thursday, June 20, 2024
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
This Skyworks Solutions Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Avi Kapoor
Workday To Rally Over 52%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Ocular Therapeutics shares are trading higher...
Benzinga Newsdesk
TD Cowen Upgrades Ocular Therapeutix to Buy, ...
Benzinga Newsdesk
Friday, June 14, 2024
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Piper Sandler Maintains Overweight on Ocular ...
Benzinga Newsdesk
Ocular Therapeutix shares are trading higher ...
Benzinga Newsdesk
Hasbro, Tutor Perini, Arm Holdings And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Deep Dive Into Ocular Therapeutix Stock: Analyst Perspectives (6 Ratings)
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk
Thursday, June 13, 2024
Ocular Therapeutix Highlights AXPAXLI SOL-1 E...
Benzinga Newsdesk
Ocular Therapeutics Announces 80% Rescue-Free...
Benzinga Newsdesk
Watching Shares Of Ocular Therapeutix, Compan...
Benzinga Newsdesk
Monday, June 03, 2024
Ocular Therapeutix Announces Strategic Reduct...
Benzinga Newsdesk
Tuesday, May 28, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Wednesday, May 08, 2024
HC Wainwright & Co. Maintains Buy on Ocular T...
Benzinga Newsdesk
JMP Securities Maintains Market Outperform on...
Benzinga Newsdesk
TD Cowen Maintains Hold on Ocular Therapeutix...
Benzinga Newsdesk
Tuesday, May 07, 2024
Ocular Therapeutix Q1 2024 Adj EPS $(0.28) Mi...
Benzinga Newsdesk
Monday, May 06, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
BioNTech Reports Downbeat Earnings, Joins Medical Properties Trust And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
Friday, April 19, 2024
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
HC Wainwright & Co. Reiterates Buy on Ocular ...
Benzinga Newsdesk
Thursday, April 18, 2024
Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye Disorder
Vandana Singh
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
Ocular Therapeutix shares are trading lower. ...
Benzinga Newsdesk
Ocular Therapeutix Reports Topline Phase 1 Da...
Benzinga Newsdesk
Tuesday, April 16, 2024
The Analyst Verdict: Ocular Therapeutix In The Eyes Of 8 Experts
Benzinga Insights
JMP Securities Reiterates Market Outperform o...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch